Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Join Sonic Foundry, Wisconsin Department of Health Services to host webinar on health information

When the spread of H1N1 flu accelerated this fall, the Wisconsin Department of Health Services needed to get more information to more people more quickly than ever before. Join Sonic Foundry, Inc. (Nasdaq: SOFO), the recognized market leader for rich media webcasting and knowledge management, for a live webinar in which Matt Duffy from the Wisconsin Department of Health Services, will share how in-house webcasting relieved fiscal pressures and made it easier to present increasingly complex data.

5 Dec 2009

Findings underscore the need for additional medical student education for healthcare reform

As the population of people with chronic conditions and health care costs rise, so do opportunities for implementing health prevention strategies. Jan Carney, M.D., M.P.H., associate dean for public health at the University of Vermont (UVM) College of Medicine, believes a critical strategy for reforming the health care system lies in teaching medical students about prevention and public health.

5 Dec 2009

Too early to declare end of H1N1 pandemic, WHO says

Though there are signs the H1N1 (swine flu) has peaked in the U.S. and Canada, a WHO flu expert said Thursday it is too early to declare the pandemic over, Canadian Press reports.

4 Dec 2009

Sudbury & District Public Health Unit nurses reach tentative settlement with employer

Following a long and difficult negotiations process, public health nurses with the Sudbury & District Public Health Unit have reached a tentative settlement with their employer.

4 Dec 2009

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Adaptive vaccination strategies, based on age patterns of hospitalizations and deaths monitored in real-time during the early stages of a pandemic, outperform seasonal influenza vaccination allocation strategies, according to findings reported Dec. 3 by researchers, including two from Arizona State University, in the online journal PLoS ONE.

4 Dec 2009

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

According to the World Health Organization, the human H1N1/09 Type A influenza ("Swine Flu") has reached a pandemic level. Over 500,000 cases have been confirmed worldwide with at least 6,500 fatalities. Since there is no longer a requirement to test and report individual cases, these numbers undoubtedly understate the real situation.

4 Dec 2009

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

The relatively low number of new cases created by a single case of H1N1 influenza indicates that mitigation strategies such as vaccination, social distancing and the use of antiviral drugs may help to lessen the final impact of the virus, suggests an epidemiological modelling study

4 Dec 2009

New medical-scientific article on A/H1N1 epidemic

A special issue of Deutsches -rzteblatt International contains the first scientific presentation of clinical experience with the novel influenza A virus (H1N1/09) in the German-speaking countries since the start of the pandemic.

4 Dec 2009

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Surgeons and other healthcare professionals specialising in solid organ transplants have been issued with expert advice to guide them through the complex clinical issues posed by the global H1N1 (swine flu) pandemic.

4 Dec 2009

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

NanoBio Corporation today announced positive results from studies in mice in which immune responses were evaluated following administration of 5µg doses of recombinant H5N1 pandemic flu antigen combined with the company’s novel nanoemulsion vaccine. These studies are unique because the adjuvant was administered for the first time by subcutaneous (SC) and intramuscular (IM) injections.

3 Dec 2009

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche's Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 Influenza Virus sequences on a regular basis.

3 Dec 2009

Roche ships additional quantities of Tamiflu oral suspension

Roche announced today that it has begun shipping additional quantities of Tamiflu® (oseltamivir phosphate) oral suspension (liquid).

3 Dec 2009

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

Novavax, Inc. today reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the company's 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico to support registration of the vaccine in Mexico and potentially other countries.

2 Dec 2009

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.

2 Dec 2009

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its fourth purchase order for its H1N1 vaccine, PANFLU.1(TM), from China's Ministry of Industry and Information Technology for the national purchase plan.

2 Dec 2009

CHG Healthcare Services implements campaign to lessen the spread of H1N1 among employees

With the height of seasonal flu season approaching and the pandemic of H1N1 in the headlines, CHG Healthcare Services has designed and mobilized a campaign to keep employees informed of the latest flu trends affecting their offices.

2 Dec 2009

CRO to run CEL-SCI's upcoming Phase III clinical trial

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today that it has retained the services of an international Contract Research Organization (CRO) to run CEL-SCI's upcoming Phase III clinical trial in advanced primary head and neck cancer with the Company's lead product candidate, Multikine®.

1 Dec 2009

Swine flu cases appear to have peaked

The current wave of pandemic H1N1 appears to have peaked, with four weeks of declines in several key indicators, the Centers for Disease Control and Prevention said Monday. Despite the decrease, the outbreak is continuing to take a heavy toll of hospitalizations and deaths, especially among children.

1 Dec 2009

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

TriCore Reference Laboratories of Albuquerque, N.M., reported at a recent user meeting results of their research collaboration with Roche Applied Science in which they evaluated Roche´s new MagNA Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen testing.

1 Dec 2009

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Akonni Biosystems, a molecular diagnostics (MDx) company focused on providing rapid and highly scalable solutions for infectious disease testing, today announced receipt of a $3.2M Phase II SBIR grant from the National Institutes of Health (NIH).

1 Dec 2009

Pandemic News and Research

Further Reading

Join Sonic Foundry, Wisconsin Department of Health Services to host webinar on health information

Findings underscore the need for additional medical student education for healthcare reform

Too early to declare end of H1N1 pandemic, WHO says

Sudbury & District Public Health Unit nurses reach tentative settlement with employer

Adaptive vaccination strategies outperform seasonal influenza vaccination allocation strategies

Integrative medicine and treatment strategies for the H1N1 infection discussed at the Buchang Forum

Vaccination, social distancing and antiviral drugs may help lessen swine flu impact

New medical-scientific article on A/H1N1 epidemic

Expert advice for organ transplant surgeons on clinical issues posed by swine flu pandemic

Positive results from NanoBio's recombinant H5N1 flu antigen-nanoemulsion vaccine combination study

Roche to provide the RealTime ready Influenza A/H1N1 Detection Set to CLIA high-complexity labs under EUA

Roche ships additional quantities of Tamiflu oral suspension

Favorable initial results from Novavax' 2009 H1N1 VLP pandemic influenza vaccine Phase II study

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

CHG Healthcare Services implements campaign to lessen the spread of H1N1 among employees

CRO to run CEL-SCI's upcoming Phase III clinical trial

Swine flu cases appear to have peaked

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

Akonni Biosystems receives $3.2M Phase II SBIR grant from NIH

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News